Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × Sirolimus × Clear all

NCT00328770 2013-06-24

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Phase 2/3 Completed

70 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular